Commercial health plan initiation of a co-pay accumulator adjustment program for specialty medications treating autoimmune diseases was associated with significant reductions in medication adherence and persistence.
Brian Meissner, PharmD, PhD
Advertisement
Articles by Brian Meissner, PharmD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
NYC Marathon Death Puts Rhabdomyolysis Risk Factors in Focus
2
Real-World Evidence, Rare Liver Disease Data Headline Kidney Week 2026
3
Cranberry Supplement Tied to Greater OAB Score Reductions in Pilot Trial
4
Disease Extent Linked to Complications After Deep Endometriosis Surgery
5